All In Biotech

Drug Trial Radar · NCT01248104

Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery

Last checked: Nov 20, 2026Latest source record: Oct 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Mar 2010

Primary completion

Mar 2013

Study completion Feb 2015

Sponsor

Lead sponsor
Loma Linda UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 25, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

We designed a prospective double-blinded randomized trial in an attempt to detect a difference between tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) in reducing transfusion in patients undergoing cardiac surgery.

Conditions

  • Cardiopulmonary Bypass

Interventions

  • Tranexamic AcidDrug

    Infusion during cardiac surgery

  • Aminocaproic AcidDrug

    Infusion during cardiac surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total Transfusion AmountsTime frame: 48 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Loma Linda University Medical Center

    Loma Linda, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.